Kemin Industries has announced that its Verona, Missouri plant, operated by Kemin Food Technologies, has received Global Food Safety Initiative certification through the Food Safety System Certification (FSSC) 22000 GFSI standard scheme, and has been successfully audited by the Agricultural Marketing Services arm of USDA for its implementation of the Process Verified Program.
Image courtesy of Kemin
Kemin Industries (Des Moines, IA) has announced that its Verona, Missouri plant, operated by Kemin Food Technologies, has received Global Food Safety Initiative certification through the Food Safety System Certification (FSSC) 22000 GFSI standard scheme. The certification verifies that the plant, dedicated to the production of Kemin’s Proteus clean label functional proteins, is effectively administering its Food Safety and Quality Management Systems.
According to the company’s press release, FSSC is among the highest levels of certifications in food safety management systems, combining “ISO 22000, a unique international standard based on the HACCP method, and ISO TS 22000-1, which was developed to specify the prerequisite programs related to Good Manufacturing Practices.” The certification requires rigorous review and audits. The facility has also earned recognition from USDA for implementation of the Process Verified Program audited by the Agricultural Marketing Services arm of the agency, as well as organic certification.
“We are thrilled to announce the Kemin Verona facility has achieved GFSI certification and is an Approved USDA Process Verified Program production plant,” said Marc Scantlin, president of Kemin Food Technologies, North America, in a press release. “These certifications are an important milestone at the facility, which was opened to support customer demand for clean label ingredient solutions. Proteus is an ideal functional protein ingredient that makes it possible for manufacturers to enhance the quality and yield of meat and poultry products, reduce input costs, and meet in-demand label claims.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.